CBDL Announces Strategic Rollout on Vibe Performance Network, Elevating 8000MG Pain Cream to National Streaming Audiences
CBD Life Sciences (OTC:CBDL) has announced a strategic partnership with the Vibe Performance Network to market its flagship 8000MG Pain Relief Cream through major streaming platforms including Hulu, ESPN+, Roku, and Discovery+.
The company will leverage Vibe's data-driven advertising platform to target health-conscious consumers with precision demographics and geographic targeting. This strategic move is expected to generate a projected 7-figure boost in annual revenue. The initiative comes as the global CBD market is forecasted to reach $22 billion by 2030, with topical CBD products expected to achieve a 32.1% CAGR.
CBD Life Sciences (OTC:CBDL) ha annunciato una partnership strategica con la Vibe Performance Network per promuovere la sua crema topica di punta, la 8000MG Pain Relief Cream, attraverso importanti piattaforme di streaming come Hulu, ESPN+, Roku e Discovery+.
L'azienda sfrutter脿 la piattaforma pubblicitaria basata sui dati di Vibe per raggiungere con precisione consumatori attenti alla salute, utilizzando criteri demografici e geografici mirati. Questa mossa strategica dovrebbe generare un aumento previsto a sette cifre nel fatturato annuo. L'iniziativa arriva in un momento in cui il mercato globale della CBD 猫 previsto raggiungere i 22 miliardi di dollari entro il 2030, con i prodotti topici a base di CBD che si prevede registreranno un CAGR del 32,1%.
CBD Life Sciences (OTC:CBDL) ha anunciado una asociaci贸n estrat茅gica con Vibe Performance Network para comercializar su crema principal, la 8000MG Pain Relief Cream, a trav茅s de plataformas de streaming importantes como Hulu, ESPN+, Roku y Discovery+.
La empresa aprovechar谩 la plataforma publicitaria basada en datos de Vibe para dirigirse con precisi贸n a consumidores preocupados por la salud, utilizando segmentaci贸n demogr谩fica y geogr谩fica. Se espera que este movimiento estrat茅gico genere un impulso proyectado de siete cifras en ingresos anuales. Esta iniciativa llega en un momento en que se pronostica que el mercado global del CBD alcanzar谩 los 22 mil millones de d贸lares para 2030, con los productos t贸picos de CBD esperando un CAGR del 32.1%.
CBD Life Sciences (OTC:CBDL)臧赌 Vibe Performance Network鞕� 鞝勲灥鞝� 韺岉姼雱堨嫮鞚� 毵宏碃 欤检殧 鞀ろ姼毽皪 頂岆灚韽检澑 Hulu, ESPN+, Roku, Discovery+毳� 韱淀暣 雽�響� 鞝滍拡鞚� 8000MG Pain Relief Cream鞚� 毵堨紑韺呿暅雼り碃 氚滍憸頄堨姷雼堧嫟.
須岇偓電� Vibe鞚� 雿办澊韯� 旮半皹 甏戧碃 頂岆灚韽检潉 頇滌毄頃� 瓯搓皶鞐� 甏�鞁澊 毵庫潃 靻岆箘鞛愲摛鞚� 鞝曧檿頃� 鞚戈惮韱店硠頃欖爜 氚� 歆�毽爜 韮�瓴燀寘鞙茧 瓿惦灥頃� 鞓堨爼鞛呺媹雼�. 鞚� 鞝勲灥鞝� 臁办箻電� 鞐瓣皠 毵れ稖鞐愳劀 7鞛愲Μ 靾� 歃濌岸�毳� 旮半寑頃橁碃 鞛堨姷雼堧嫟. 鞚措矆 瓿勴殟鞚� 鞝� 靹戈硠 CBD 鞁滌灔鞚� 2030雲勱箤歆� 220鞏� 雼煬鞐� 鞚措ゼ 瓴冹溂搿� 鞓堨儊霅橂┌, 甑唽鞖� CBD 鞝滍拡鞚� 鞐绊弶攴� 靹膘灔毳�(CAGR) 32.1%鞚� 旮半頃� 瓴冹溂搿� 鞝勲霅橂姅 鞁滌爯鞐� 氚滍憸霅橃棃鞀惦媹雼�.
CBD Life Sciences (OTC:CBDL) a annonc茅 un partenariat strat茅gique avec le Vibe Performance Network pour commercialiser sa cr猫me phare, la 8000MG Pain Relief Cream, via des plateformes de streaming majeures telles que Hulu, ESPN+, Roku et Discovery+.
L'entreprise utilisera la plateforme publicitaire bas茅e sur les donn茅es de Vibe pour cibler avec pr茅cision les consommateurs soucieux de leur sant茅, en utilisant un ciblage d茅mographique et g茅ographique pr茅cis. Cette initiative strat茅gique devrait g茅n茅rer une augmentation annuelle des revenus 脿 sept chiffres. Ce projet intervient alors que le march茅 mondial du CBD devrait atteindre 22 milliards de dollars d'ici 2030, avec une croissance annuelle compos茅e (CAGR) pr茅vue de 32,1 % pour les produits topiques 脿 base de CBD.
CBD Life Sciences (OTC:CBDL) hat eine strategische Partnerschaft mit dem Vibe Performance Network angek眉ndigt, um seine Flaggschiff-Creme 8000MG Pain Relief Cream 眉ber gro脽e Streaming-Plattformen wie Hulu, ESPN+, Roku und Discovery+ zu vermarkten.
Das Unternehmen wird die datengesteuerte Werbeplattform von Vibe nutzen, um gesundheitsbewusste Verbraucher mit pr盲ziser demografischer und geografischer Zielgruppenansprache anzusprechen. Dieser strategische Schritt soll einen prognostizierten siebenstelligen Umsatzanstieg pro Jahr generieren. Die Initiative erfolgt zu einem Zeitpunkt, an dem der globale CBD-Markt bis 2030 voraussichtlich 22 Milliarden US-Dollar erreichen wird, wobei topische CBD-Produkte voraussichtlich eine j盲hrliche Wachstumsrate (CAGR) von 32,1% erzielen.
- Integration with major streaming platforms like Hulu, ESPN+, Roku, and Discovery+ expands national reach
- Projected 7-figure annual revenue boost from the 8000MG Pain Cream campaign
- Access to performance-optimized advertising with lower costs than traditional platforms
- Targeting capability in the growing CBD market, forecast to reach $22B by 2030
- Heavy reliance on marketing success for revenue growth
- Operating in the highly competitive CBD market
CBD Life Sciences Inc. (OTC:CBDL) expands its digital advertising arsenal through the Vibe Performance Network, positioning its flagship 8000MG Pain Cream in front of millions of engaged, wellness-focused viewers - unlocking massive revenue potential and long-term shareholder value in the booming CBD market.
SCOTTSDALE, ARIZONA / / July 8, 2025 / CBD Life Sciences Inc. (OTC:CBDL), parent company of CBD Vault, is thrilled to announce a transformational leap in its national marketing strategy through integration with Vibe, a cutting-edge self-serve streaming TV advertising platform. This strategic move empowers CBDL to deliver targeted, data-driven campaigns across top-tier streaming platforms including Hulu, ESPN+, Roku, Discovery+, Tubi, and dozens of other premium outlets.
As part of this rollout, CBDL will begin aggressively marketing its new 8000MG Pain Relief Cream - its most potent and in-demand product to date. Designed for athletes, chronic pain sufferers, and everyday individuals seeking fast, long-lasting relief, the 8000MG Pain Cream delivers unparalleled results - and now, it will reach a national audience with unmatched precision.
"This initiative represents one of the most important and scalable steps forward in CBDL's history," said Lisa Nelson, President & CEO of CBDL. "With Vibe, we're not just buying ad space - we're owning the channel to our core audience. This technology allows us to place the right product in front of the right person at the right time. That means greater efficiency, greater visibility, and greater returns."
The Vibe Advantage: Why This is a Major Inflection Point for CBDL
CBDL's integration with the Vibe Performance Network gives the company unprecedented access to millions of health-conscious consumers across the U.S., including targeted audiences based on:
Demographics (age, gender, income)
Behavioral habits and content interests
Zip-code level geographic targeting
Engagement with wellness, recovery, fitness, and CBD-related content
Unlike traditional TV or social media ads, Vibe campaigns are performance-optimized - allowing for real-time analytics, creative testing, and dynamic budget scaling, all while keeping advertising costs significantly lower than legacy platforms.
Projected Revenue Impact and Market Positioning
With this expanded visibility, CBDL is now positioned to unlock significant recurring revenue across both direct-to-consumer and wholesale channels. Based on historical customer conversion data and industry benchmarks, the 8000MG Pain Cream campaign alone could drive a projected 7-figure boost in annual revenue, with the potential to scale beyond as CBD Vault's product line continues to grow.
This launch directly supports the company's mission of becoming a nationally recognized leader in natural wellness solutions, while laying the groundwork for future product launches using the same Vibe infrastructure.
The global CBD market is forecasted to exceed
CBDL's powerful combination of product efficacy, consumer trust, and now digital ad precision, gives the company a major competitive edge as it scales nationwide.
Investor Significance
For current and prospective investors, this strategic deployment represents a material turning point in how the company markets, sells, and scales. By implementing a scalable, intelligent advertising ecosystem, CBDL is no longer reliant on outdated, inefficient marketing tactics - instead embracing the same programmatic tools used by Fortune 500 brands, tailored for the cannabis and wellness space.
In essence, CBDL now controls its own national media pipeline, giving the company the ability to:
Increase customer acquisition at lower costs
Expand brand awareness across multiple demographics
Support higher margins and longer customer lifetime value
Launch future products into an already-primed national audience
"This is more than just a campaign - it's infrastructure," added Nelson. "It's a system that can be used again and again to take new products to market, drive sales, and fuel consistent growth. It's a future-proof marketing engine."
Vibe Platform Website :
About CBD Life Sciences Inc. (CBDL)
CBD Life Sciences Inc. is an innovative health and wellness company committed to the research, development, and distribution of premium cannabidiol (CBD) products through its core brand, CBD Vault. From topicals and tinctures to wellness beverages and skincare solutions, CBDL is building a portfolio of products designed for maximum efficacy, transparency, and consumer trust.
Follow our social media for the latest updates!
X:
Instagram:
IR Contact: [email protected]
Stay Connected & Be the First to Try Our New Functional Mushroom Products!
Mushroom Madness Instagram:
Mushroom Madness Website:
Forward-Looking Statements
Except for the historical information contained herein, the matters discussed in this press release are forward-looking statements. Actual results may differ materially from those described in forward-looking statements and are subject to risks and uncertainties. See CBD Life Sciences, Inc's, Inc.'s filings with OTC Markets, which may identify specific factors that may cause actual results or events to differ materially from those described in the forward-looking statements.
Safe Harbor Statement
This release includes forward-looking statements, which are based on certain assumptions and reflects management's current expectations. These forward-looking statements are subject to a number of risks and uncertainties that could cause actual results or events to differ materially from current expectations. Some of these factors include: general global economic conditions; general industry and market conditions, sector changes and growth rates; uncertainty as to whether our strategies and business plans will yield the expected benefits; increasing competition; availability and cost of capital; the ability to identify and develop and achieve commercial success; the level of expenditures necessary to maintain and improve the quality of services; changes in the economy; changes in laws and regulations, including codes and standards, intellectual property rights, and tax matters; or other matters not anticipated; our ability to secure and maintain strategic relationships and distribution agreements. The Company disclaims any intention or obligation to update or revise any forward-looking ability to secure and maintain strategic relationships and distribution agreements. The Company disclaims any intention or obligation to update or revise any forward-looking statements.
Contact Information
Lisa Nelson
CEO
4802091720
SOURCE: CBD Life Sciences, Inc.
View the original on ACCESS Newswire
FAQ
What streaming platforms will CBDL advertise its CBD products on?
What is the revenue potential for CBDL's 8000MG Pain Cream campaign?
What is the market forecast for CBD topical products?
How will CBDL target customers through the Vibe Performance Network?
What advantages does the Vibe platform offer CBDL?
